Pharmacogenomics of scopoletin in tumor cells

EJ Seo, M Saeed, BYK Law, AG Wu, O Kadioglu… - Molecules, 2016 - mdpi.com
Drug resistance and the severe side effects of chemotherapy necessitate the development of
novel anticancer drugs. Natural products are a valuable source for drug development …

An overview of the pharmacological activities of scopoletin against different chronic diseases

D Parama, S Girisa, E Khatoon, A Kumar… - Pharmacological …, 2022 - Elsevier
Chronic diseases are considered a major public health concern worldwide, and most of
these diseases like cancer, cardiovascular, metabolic, and neurological disorders occur due …

Scopoletin: a review of its pharmacology, pharmacokinetics, and toxicity

XY Gao, XY Li, CY Zhang, CY Bai - Frontiers in Pharmacology, 2024 - frontiersin.org
Scopoletin is a coumarin synthesized by diverse medicinal and edible plants, which plays a
vital role as a therapeutic and chemopreventive agent in the treatment of a variety of …

Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer

C Yuan, MH Wang, F Wang, PY Chen, XG Ke, B Yu… - Life sciences, 2021 - Elsevier
Aims Scopoletin is a natural anticarcinogenic and antiviral coumarin component. Many
studies have proved its anti-cancer effect, and after the preliminary screening of this study …

Scopoletin: anticancer potential and mechanism of action

L Meilawati, RM Dewi, AN Tasfiyati… - Asian Pacific Journal …, 2023 - journals.lww.com
Cancer is considered a leading cause of death worldwide due to its high morbidity and
mortality rate. Conventional treatments for cancer therapy, such as chemotherapy, and …

[HTML][HTML] Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway

N Li, F Yang, DY Liu, JT Guo, N Ge… - World journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Pancreatic cancer is a highly malignant tumor of the gastrointestinal system
whose emerging resistance to chemotherapy has necessitated the development of novel …

The antiangiogenic and antitumor effects of scoparasin B in non-small-cell lung cancer

K Lin, L Huang, Y Zhang, M Chen, Z Li… - Journal of Natural …, 2023 - ACS Publications
Angiogenesis and vasculogenic mimicry (VM) are crucial for the growth and metastasis of
non-small-cell lung cancer (NSCLC). Most tumor angiogenesis inhibitors mainly target …

Anti‐angiogenic potential of scopoletin is associated with the inhibition of ERK1/2 activation

R Pan, Y Dai, J Yang, Y Li, X Yao… - Drug Development …, 2009 - Wiley Online Library
Angiogenesis plays an important role in many diseases, such as cancer, rheumatoid
arthritis, and diabetic retinopathy. Specific inhibitors of angiogenesis are therefore expected …

Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular …

M Saeed, V Kuete, O Kadioglu, J Börtzler, H Khalid… - Phytomedicine, 2014 - Elsevier
A main problem in oncology is the development of drug-resistance. Some plant-derived
lignans are established in cancer therapy, eg. the semisynthetic epipodophyllotoxins …

Scopolin obtained from Smilax china L. against hepatocellular carcinoma by inhibiting glycolysis: A network pharmacology and experimental study

C Wang, Q Zhou, ST Wu - Journal of Ethnopharmacology, 2022 - Elsevier
Ethnopharmacological relevance Smilax china L. is a well-known traditional medicinal plant.
In China, it is a common anti-cancer drug that has been inherited for thousands of years …